Hologic (HOLX) Saham Harga
Hologic Harga
Selama 19 tahun terakhir pendapatan Hologic tumbuh 12,2% per tahun, mencapai 4,10 miliar USD. Laba per saham tumbuh 12,8% per tahun selama 19 tahun terakhir. Bagi Hologic, margin bersih sebesar 13,8% turun dibanding 33,2% beberapa tahun lalu. Target harga konsensus 12 bulan untuk Hologic adalah 77,52 USD, sekitar di atas harga saat ini 2,0%. Dari 23 analis, 0 merekomendasikan beli — konsensus keseluruhan Tahan.
Harga saham Hologic
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Hologic
Pertanyaan yang sering diajukan tentang saham Hologic
The main competitors of Hologic Inc in the market include companies like Abbott Laboratories, Thermo Fisher Scientific, and Becton, Dickinson and Company.
The business model of Hologic Inc revolves around providing innovative diagnostic solutions, primarily focused on women's healthcare. Hologic develops and markets a wide range of medical devices and instruments, including imaging systems, surgical products, and molecular diagnostic assays. The company's products are designed to enable healthcare professionals to effectively screen, diagnose, and treat various conditions and diseases. Hologic is renowned for its advanced technologies in breast health, gynecology, and skeletal health, offering solutions that empower early detection and intervention. By constantly pushing the boundaries of medical technology, Hologic Inc remains committed to improving healthcare outcomes for women around the world.
Hologic Inc is primarily active in the healthcare industry, specifically in the field of diagnostic products and medical devices. With a focus on improving women's health, Hologic Inc develops and manufactures a wide range of innovative solutions. Their portfolio includes advanced imaging systems, molecular diagnostic assays, surgical instruments, and women's health screening tests. As a prominent player in the healthcare sector, Hologic Inc constantly strives to provide cutting-edge technologies and solutions to address various medical challenges.
Hologic Inc is a leading global healthcare and diagnostics company. Established in 1985, Hologic has excelled in providing innovative solutions for women's health, with a focus on early detection and treatment of breast and cervical cancers. The company's dedication to research and development has resulted in breakthrough technologies, including the introduction of the first 3D mammography system. Hologic has expanded its portfolio to include diagnostics, surgical and skeletal health, and GYN surgical products. With a strong commitment to advancing healthcare, Hologic Inc continues to make significant contributions to improving patient outcomes and quality of life.
Hologic Inc, a leading healthcare company, has achieved several significant milestones. In recent years, the company has made notable advancements in breast health solutions. They introduced the world's first 3D mammography system, which revolutionized breast cancer detection by providing clearer and more accurate images. Hologic Inc also developed the Genius™ 3D Mammography™ exam, proven to detect breast cancer at an earlier stage compared to 2D mammography alone. Furthermore, the company expanded its portfolio by acquiring Gen-Probe, a molecular diagnostics company, allowing Hologic Inc to offer a comprehensive range of diagnostic solutions. These milestones highlight Hologic Inc's commitment to innovation and improving women's healthcare outcomes.
Hologic Inc is primarily present in various countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered. Additionally, Hologic Inc operates in Europe, including countries like Germany, France, Italy, and the United Kingdom. It also has a presence in Asia, particularly in countries such as China and Japan. Furthermore, Hologic Inc serves customers in Canada and Latin America, with a focus on countries like Mexico and Brazil. Overall, Hologic Inc has a global reach and aims to provide its products and services to diverse markets internationally.
Hologic Inc represents values of innovation, commitment to quality, and patient-centric approach. The corporate philosophy of Hologic Inc revolves around developing cutting-edge medical technologies to improve women's health outcomes. With a focus on providing accurate and reliable diagnostic solutions, Hologic Inc strives to empower healthcare professionals and patients alike. The company's dedication to research and development, evidence-based practices, and collaboration with healthcare experts reinforces its commitment to advancing healthcare for women globally. Hologic Inc's mission is to make a difference in people's lives through advanced healthcare solutions, making them a trusted and reliable leader in the industry.
Analis saat ini menetapkan target harga rata-rata 76,66 USD untuk saham Hologic (median: 77,52 USD), yaitu +0,9 % terhadap harga terbaru. Konsensus didasarkan pada 23 peringkat analis.
23 analis saat ini menilai saham Hologic: 0 merekomendasikan beli, 20 tahan, dan 3 jual. Untuk 2026, analis memperkirakan Hologic menghasilkan pendapatan 4,24 miliar USD dan laba per saham 4,49 USD.
Dengan kurs saat ini, saham Hologic diperdagangkan pada 67,95 EUR (76,01 USD).
Saham Hologic (HOLX) tercatat di 9 bursa, termasuk: NASDAQ (HOLX), London (0J5Q.L), SIX (Zürich) (HO1.SW), XETRA (HO1.DE), Frankfurt (HO1.F), München (HO1.MU), Düsseldorf (HO1.DU), Wien (HOLX.VI).
Hologic Inc is an international leading provider of medical technology products and solutions. The company, headquartered in Marlborough, Massachusetts, operates globally and is divided into four business segments: Diagnostics, Gynecology, Skeletal Health, and Aesthetics.
Pendapatan diperkirakan dari Hologic adalah 4,24 miliar USD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba diperkirakan dari Hologic adalah 1,01 miliar USD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Hologic saat ini adalah 16,93. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Hologic.
Rasio harga-terhadap-penjualan (PSR) Hologic saat ini adalah 4,05. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Hologic.
Skor Kualitas AlleAktien untuk Hologic adalah 1/10.
ISIN dari Hologic adalah US4364401012. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Hologic adalah 879100. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Hologic adalah HOLX. Simbol ticker digunakan untuk memperdagangkan saham Hologic di bursa saham.
Saham Hologic
Kelompok Peer Hologic
Hologic Ticker
Hologic FIGI
Semua metrik fundamental dan analisis mendalam Hologic
Analisis saham kami untuk saham Hologic mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Hologic. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.